Cystitis is an inflammation of the bladder due to infection with a microorganism (such as a bacteria or virus). Cystitis is second only to
The National Kidney Foundation estimates that 10 to 20 percent of women have had at least one episode of cystitis, and 80 percent of this group has had it recurrently.
Although some cases of cystitis are due to fungus or a virus, most are caused by one of several types of bacteria. The most common, Escherichia coli,...
Our thoughts are with the patients and families in Europe who recently developed PML (Progressive Multifocal Leukoencephalopathy) on... Read more »
Tysabri, a drug initially used to treat Multiple Sclerosis has been approved for use in certain patients with Crohn's disease. This drug is... Read more »
There have been a few items in the news lately related to Inflammatory Bowel Disease that I thought prudent to pass along to... Read more »
Tysabri has been in the news again this week. Last Friday the European Medicines Agency (EMEA) announced that they would review the... Read more »
No, this is not the beginning of a Scrabble® game. PML stands for Progressive Multifocal Leukoencephalopathy. Is that even more confusing?... Read more »
Crohn's patients who have unusual moles or a history of skin cancer should talk to their doctor before taking Tysabri, a new study suggests.... Read more »
Source: HealthCentral Encyclopedia
A urinary tract infection (UTI) is an inflammation of the bladder due to infection with a microorganism (such as a bacteria or virus). It is also... Read more »
According to a new study, Tysabri significantly increases the proportion of disease-free patients with relapsing multiple sclerosis (MS) compared... Read more »
Source: First DataBank
Generic Name: NATALIZUMAB - INJECTION Pronounced: (nay-tal-IZ-oo-mab) Warning Natalizumab increases your risk of getting a rare but very serious... Read more »
New research suggests that the drug Tysabri may regenerate and stabilize damage done to the myelin sheath in people with multiple sclerosis (MS). In... Read more »